首页 > 最新文献

Open research Africa最新文献

英文 中文
Funding and COVID-19 research in Africa: two years on, are the research needs of Africa being met? 非洲的资金和COVID-19研究:两年过去了,非洲的研究需求得到满足了吗?
Pub Date : 2023-09-12 DOI: 10.12688/openresafrica.14185.1
Emilia Antonio, Moses Alobo, Marta Tufet Bayona, Kevin Marsh, Proochista Ariana, Alice Norton
Background: The Coronavirus disease 2019 (COVID-19) pandemic caused significantly lower reported mortalities on the African continent as compared to other regions. Yet, many countries on the continent are still contending with the devastating economic, social and indirect health impacts. African researchers and policy makers have identified research priority areas which take cognisance of the unique research needs of African countries. A baseline assessment of the alignment of funded research in Africa to these priorities and World Health Organization’s COVID-19 research priorities was undertaken in July, 2020. We present a two-year update to this analysis of funded COVID-19 research in Africa. Methods: Data captured in the UK Collaborative on Development Research and Global Research Collaboration for Infectious Disease Preparedness COVID-19 Research Project Tracker as of 15th July, 2022 was analysed. An additional analysis of institutions receiving funding for COVID-19 research is presented. We also analysed the change in funding for COVID-19 research in Africa since July, 2020. Results: The limited COVID-19 research identified in Africa early in the pandemic has persisted over the subsequent two-year period assessed. When number of projects are considered, governmental funders based in Europe and United States supported the most research. Only nine research funders based in Africa were identified. A number of partnerships between African institutions and institutions based on other continents were identified, however, most research projects were undertaken in research institutions based in Africa only. Our findings highlight the relevance of the WHO research priorities for the pandemic response in Africa. Many research questions raised by African researchers remain unaddressed, among which are questions related to clinical management of COVID-19 infections in Africa. Conclusions: Two years after the identification of Africa’s COVID-19 research priorities, the findings suggest a missed opportunity in new research funding to answer pertinent questions for the pandemic response in Africa.
背景:与其他地区相比,2019年冠状病毒病(COVID-19)大流行在非洲大陆造成的报告死亡率显着降低。然而,非洲大陆许多国家仍在与破坏性的经济、社会和间接健康影响作斗争。非洲科学家和决策者已经确定了考虑到非洲国家独特的研究需求的研究优先领域。2020年7月,对非洲资助的研究与这些优先事项和世界卫生组织COVID-19研究优先事项的一致性进行了基线评估。我们对非洲受资助的COVID-19研究进行了为期两年的最新分析。方法:分析截至2022年7月15日英国发展研究协作和全球传染病防范研究协作COVID-19研究项目跟踪器捕获的数据。对获得COVID-19研究资金的机构进行了进一步分析。我们还分析了自2020年7月以来非洲COVID-19研究经费的变化。结果:在大流行早期在非洲确定的有限的COVID-19研究在随后评估的两年期间持续存在。如果考虑到项目的数量,欧洲和美国的政府资助者支持的研究最多。只有9个非洲的研究资助者被确定。非洲机构与设在其他大陆的机构之间确定了若干伙伴关系,但是,大多数研究项目只在设在非洲的研究机构进行。我们的研究结果突出了世卫组织研究重点与非洲大流行应对的相关性。非洲研究人员提出的许多研究问题仍未得到解决,其中包括与非洲COVID-19感染的临床管理有关的问题。结论:在确定非洲COVID-19研究重点两年后,研究结果表明,在新的研究资助方面错失了回答非洲大流行应对相关问题的机会。
{"title":"Funding and COVID-19 research in Africa: two years on, are the research needs of Africa being met?","authors":"Emilia Antonio, Moses Alobo, Marta Tufet Bayona, Kevin Marsh, Proochista Ariana, Alice Norton","doi":"10.12688/openresafrica.14185.1","DOIUrl":"https://doi.org/10.12688/openresafrica.14185.1","url":null,"abstract":"<ns4:p>Background: The Coronavirus disease 2019 (COVID-19) pandemic caused significantly lower reported mortalities on the African continent as compared to other regions. Yet, many countries on the continent are still contending with the devastating economic, social and indirect health impacts. African researchers and policy makers have identified research priority areas which take cognisance of the unique research needs of African countries. A baseline assessment of the alignment of funded research in Africa to these priorities and World Health Organization’s COVID-19 research priorities was undertaken in July, 2020. We present a two-year update to this analysis of funded COVID-19 research in Africa.</ns4:p><ns4:p> Methods: Data captured in the UK Collaborative on Development Research and Global Research Collaboration for Infectious Disease Preparedness COVID-19 Research Project Tracker as of 15th July, 2022 was analysed. An additional analysis of institutions receiving funding for COVID-19 research is presented. We also analysed the change in funding for COVID-19 research in Africa since July, 2020.</ns4:p><ns4:p> Results: The limited COVID-19 research identified in Africa early in the pandemic has persisted over the subsequent two-year period assessed. When number of projects are considered, governmental funders based in Europe and United States supported the most research. Only nine research funders based in Africa were identified. A number of partnerships between African institutions and institutions based on other continents were identified, however, most research projects were undertaken in research institutions based in Africa only. Our findings highlight the relevance of the WHO research priorities for the pandemic response in Africa. Many research questions raised by African researchers remain unaddressed, among which are questions related to clinical management of COVID-19 infections in Africa.</ns4:p><ns4:p> Conclusions: Two years after the identification of Africa’s COVID-19 research priorities, the findings suggest a missed opportunity in new research funding to answer pertinent questions for the pandemic response in Africa.</ns4:p>","PeriodicalId":74358,"journal":{"name":"Open research Africa","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135878762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lumefantrine pressure selects nonsynonymous mutation in cysteine desulfurase IscS gene in the rodent malaria parasite Plasmodium berghei ANKA 甲苯胺压力在啮齿动物疟原虫伯氏疟原虫中选择半胱氨酸脱硫酶IscS基因的非同义突变
Pub Date : 2023-09-08 DOI: 10.12688/openresafrica.13457.3
Beatrice Gachie, Jean Chepngetich, Brenda Muriithi, Kelvin Thiong’o, Jeremiah Gathirwa, Francis Kimani, Peter Mwitari, Gabriel Magoma, Daniel Kiboi
Background: Lumefantrine (LM), piperaquine (PQ), and amodiaquine (AQ) are the essential long-acting partner drugs in the artemisinin-based combination therapies (ACTs) treatment regimens globally. The recent report on the emergence of artemisinin-resistant parasites portends an imminent failure of the partner drug in clearing the high residual parasite densities. Understanding the resistance mechanisms to partner drugs remains critical for tracking resistant parasites. Cysteine desulfurase IscS (nfs1), one of the proteins involved in the iron-sulfur (FeS) biogenesis pathway, has been implicated in mediating malaria parasite drug resistance. Methods: Using the rodent malaria parasites Plasmodium berghei ANKA in mice, we assessed whether the nfs1 gene is associated with LM, PQ, and AQ resistance. We first verified the stability of the LM, PQ, and AQ-resistant parasites in the standard 4-Day Suppressive Test. By means of PCR and sequencing analysis, we probed for single nucleotide polymorphisms (SNPs) in the nfs1 gene. Using qPCR, we then measured the expression of the nfs1 gene in resistant parasites relative to the drug-sensitive parent parasites. Results: Our analyses of nfs1 reveal a non-synonymous Gln142Arg mutation in the LM and PQ-resistant parasites. This mutation was not detected in the AQ-resistant parasites. The mRNA quantification of the nfs1 gene reveals differential expression in both LM and PQ-resistant parasites. Conversely, nfs1 expression remained unchanged in the AQ-resistant parasites. Conclusion: Our data suggest that LM and PQ selection pressure induces nonsynonymous mutation and differential expression of the nfs1 gene in Plasmodium berghei. Collectively, these findings provide a premise for investigating LM and PQ resistance mechanisms in both P. berghei and P. falciparum.
背景:氨芳汀(LM)、哌喹(PQ)和阿莫地喹(AQ)是全球以青蒿素为基础的联合疗法(ACTs)治疗方案中必不可少的长效伴用药。最近关于出现青蒿素耐药寄生虫的报告预示着伴侣药物在清除高残留寄生虫密度方面即将失败。了解对伴侣药物的耐药机制对于追踪耐药寄生虫仍然至关重要。半胱氨酸脱硫酶IscS (nfs1)是参与铁硫(FeS)生物发生途径的蛋白之一,在介导疟疾寄生虫耐药性过程中发挥了重要作用。方法:采用小鼠感染的伯氏疟原虫ANKA检测nfs1基因是否与LM、PQ和AQ耐药相关。我们首先在标准的4天抑制试验中验证了LM、PQ和aq耐药寄生虫的稳定性。通过PCR和测序分析,我们检测了nfs1基因的单核苷酸多态性(SNPs)。然后,我们使用qPCR检测了耐药寄生虫中nfs1基因相对于药物敏感亲本寄生虫的表达。结果:我们对nfs1的分析显示,在LM和pq抗性寄生虫中存在非同义的Gln142Arg突变。该突变未在抗aq寄生虫中检测到。nfs1基因的mRNA定量分析显示,在LM和pq抗性寄生虫中,nfs1基因的表达存在差异。相反,nfs1的表达在抗aq寄生虫中保持不变。结论:我们的数据表明,LM和PQ选择压力诱导了伯格氏疟原虫nfs1基因的非同义突变和差异表达。总之,这些发现为研究柏氏疟原虫和恶性疟原虫的LM和PQ耐药机制提供了前提。
{"title":"Lumefantrine pressure selects nonsynonymous mutation in cysteine desulfurase IscS gene in the rodent malaria parasite Plasmodium berghei ANKA","authors":"Beatrice Gachie, Jean Chepngetich, Brenda Muriithi, Kelvin Thiong’o, Jeremiah Gathirwa, Francis Kimani, Peter Mwitari, Gabriel Magoma, Daniel Kiboi","doi":"10.12688/openresafrica.13457.3","DOIUrl":"https://doi.org/10.12688/openresafrica.13457.3","url":null,"abstract":"<ns4:p><ns4:bold>Background:</ns4:bold> Lumefantrine (LM), piperaquine (PQ), and amodiaquine (AQ) are the essential long-acting partner drugs in the artemisinin-based combination therapies (ACTs) treatment regimens globally. The recent report on the emergence of artemisinin-resistant parasites portends an imminent failure of the partner drug in clearing the high residual parasite densities. Understanding the resistance mechanisms to partner drugs remains critical for tracking resistant parasites. Cysteine desulfurase IscS (<ns4:italic>nfs1</ns4:italic>), one of the proteins involved in the iron-sulfur (FeS) biogenesis pathway, has been implicated in mediating malaria parasite drug resistance. </ns4:p><ns4:p> <ns4:bold>Methods:</ns4:bold> Using the rodent malaria parasites <ns4:italic>Plasmodium berghei </ns4:italic>ANKA in mice, we assessed whether the <ns4:italic>nfs1</ns4:italic> gene is associated with LM, PQ, and AQ resistance. We first verified the stability of the LM, PQ, and AQ-resistant parasites in the standard 4-Day Suppressive Test. By means of PCR and sequencing analysis, we probed for single nucleotide polymorphisms (SNPs) in the <ns4:italic>nfs1</ns4:italic> gene. Using qPCR, we then measured the expression of the <ns4:italic>nfs1 </ns4:italic>gene in resistant parasites relative to the drug-sensitive parent parasites. </ns4:p><ns4:p> <ns4:bold>Results:</ns4:bold> Our analyses of <ns4:italic>nfs1</ns4:italic> reveal a non-synonymous Gln142Arg mutation in the LM and PQ-resistant parasites. This mutation was not detected in the AQ-resistant parasites. The mRNA quantification of the <ns4:italic>nfs1</ns4:italic> gene reveals differential expression in both LM and PQ-resistant parasites. Conversely, <ns4:italic>nfs1 </ns4:italic>expression remained unchanged in the AQ-resistant parasites.</ns4:p><ns4:p> <ns4:bold>Conclusion:</ns4:bold> Our data suggest that LM and PQ selection pressure induces nonsynonymous mutation and differential expression of the <ns4:italic>nfs1 </ns4:italic>gene in <ns4:italic>Plasmodium berghei</ns4:italic>. Collectively, these findings provide a premise for investigating LM and PQ resistance mechanisms in both <ns4:italic>P. berghei</ns4:italic> and <ns4:italic>P. falciparum</ns4:italic>.</ns4:p>","PeriodicalId":74358,"journal":{"name":"Open research Africa","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136299568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognitive Stimulation Therapy for older people with Dementia in Africa: A Scoping Review 非洲老年痴呆患者的认知刺激疗法:范围综述
Pub Date : 2023-06-13 DOI: 10.12688/openresafrica.14092.1
Stephen Ojiambo Wandera, E. Duncan, Monica M. Diaz, D. Ayuku
Background: Cognitive Stimulation Therapy (CST) is a non-pharmacological intervention developed for dementia that is useful in Africa but has not been studied widely. We reviewed the existing evidence regarding CST among older people living with dementia in Africa. Methods: A systematic literature search on CST among older people with dementia in Africa from 2000-2021 was done in MEDLINE (PubMed), CINAHL (EBSCOhost), and PsycINFO. A narrative approach was taken to chart, synthesize and interpret the data using Microsoft Excel. Results: After removing duplicates using Endnote, a total of 122 studies were retained and screened first by title, then abstract, and finally by full text. Seven articles matched the inclusion/exclusion criteria. CST has been adapted and piloted in two African countries (Nigeria and Tanzania). CST studies in Africa indicate improvements in clinical outcomes including cognition and quality of life. Although there are some barriers to overcome, CST has significant facilitators in an African context. Conclusions: CST is feasible, adaptable, and acceptable in the African countries it has been implemented in. Some cultural barriers, such as religious affiliation and respect for older people, should be overcome. Further research is needed to further evaluate the efficacy of CST in various African contexts.
背景:认知刺激疗法(CST)是一种针对痴呆症的非药物干预措施,在非洲很有用,但尚未得到广泛研究。我们回顾了有关非洲老年痴呆患者CST的现有证据。方法:在MEDLINE (PubMed)、CINAHL (EBSCOhost)和PsycINFO中对2000-2021年非洲老年痴呆患者的CST进行系统文献检索。采用叙述性的方法,使用Microsoft Excel对数据进行制图、综合和解释。结果:在使用Endnote删除重复项后,共有122项研究被保留下来,并先按标题筛选,然后按摘要筛选,最后按全文筛选。7篇文章符合纳入/排除标准。在两个非洲国家(尼日利亚和坦桑尼亚)调整和试行了国家科技法。在非洲进行的CST研究表明,包括认知和生活质量在内的临床结果有所改善。虽然有一些障碍需要克服,但在非洲背景下,科技类项目具有重要的促进作用。结论:CST在已经实施的非洲国家是可行的、适应性强的和可接受的。应该克服一些文化障碍,例如宗教信仰和对老年人的尊重。需要进行进一步的研究,以进一步评价国家技术支助在非洲各种情况下的效力。
{"title":"Cognitive Stimulation Therapy for older people with Dementia in Africa: A Scoping Review","authors":"Stephen Ojiambo Wandera, E. Duncan, Monica M. Diaz, D. Ayuku","doi":"10.12688/openresafrica.14092.1","DOIUrl":"https://doi.org/10.12688/openresafrica.14092.1","url":null,"abstract":"Background: Cognitive Stimulation Therapy (CST) is a non-pharmacological intervention developed for dementia that is useful in Africa but has not been studied widely. We reviewed the existing evidence regarding CST among older people living with dementia in Africa. Methods: A systematic literature search on CST among older people with dementia in Africa from 2000-2021 was done in MEDLINE (PubMed), CINAHL (EBSCOhost), and PsycINFO. A narrative approach was taken to chart, synthesize and interpret the data using Microsoft Excel. Results: After removing duplicates using Endnote, a total of 122 studies were retained and screened first by title, then abstract, and finally by full text. Seven articles matched the inclusion/exclusion criteria. CST has been adapted and piloted in two African countries (Nigeria and Tanzania). CST studies in Africa indicate improvements in clinical outcomes including cognition and quality of life. Although there are some barriers to overcome, CST has significant facilitators in an African context. Conclusions: CST is feasible, adaptable, and acceptable in the African countries it has been implemented in. Some cultural barriers, such as religious affiliation and respect for older people, should be overcome. Further research is needed to further evaluate the efficacy of CST in various African contexts.","PeriodicalId":74358,"journal":{"name":"Open research Africa","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42631000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Public engagement by early career researchers in East Africa during the COVID-19 pandemic: case studies from East Africa 2019冠状病毒病大流行期间东非早期职业研究人员的公众参与:来自东非的案例研究
Pub Date : 2023-03-20 DOI: 10.12688/openresafrica.13897.1
Trizah K. Milugo, Mary V. Mosha, E. Wampande, Rune N Philemon, Immaculate N. Lwanga, J. Seeley, Nelson K Sewankambo
Background: Community engagement and involvement (CEI) in research usually depends on face-to-face interactions. However, the COVID-19 pandemic prevented such interactions because of national lockdowns and social distancing. This paper highlights the ways in which early career researchers from East Africa tackled CEI activities during the pandemic. Methods: We provide four case examples that illustrate how early-career researchers based in Kenya, Uganda and Tanzania, deployed different approaches and initiatives to community-engaged research during the pandemic to encourage participation and uptake of research findings. Results: All the three early-career researchers attempted to use virtual/digital means to implement the CEI. However, in each country, this attempt was unsuccessful because of poor connectivity, as well as many poorer students lacking access to telephones and computers. Nevertheless, the researchers effectively engaged the students using different activities (making up songs, drawing comics, and taking part in quizzes) once the schools reopened. Conclusion: These results highlight the complexity of implementing community engagement and involvement in health research when face-to-face interaction is not possible. The findings are relevant to researchers who wish to incorporate community engagement in their research and initiatives.
背景:社区参与研究通常取决于面对面的互动。然而,由于全国封锁和保持社交距离,新冠肺炎大流行阻止了此类互动。本文重点介绍了东非早期职业研究人员在疫情期间处理CEI活动的方式。方法:我们提供了四个案例,说明肯尼亚、乌干达和坦桑尼亚的早期职业研究人员如何在疫情期间部署不同的方法和举措进行社区参与研究,以鼓励参与和吸收研究结果。结果:三位早期职业研究人员都试图使用虚拟/数字手段来实现CEI。然而,在每个国家,这种尝试都没有成功,因为连通性差,而且许多贫困学生无法使用电话和电脑。尽管如此,一旦学校重新开放,研究人员就通过不同的活动(编歌曲、画漫画和参加测验)有效地让学生参与进来。结论:这些结果突出了在无法进行面对面的互动的情况下,实施社区参与和参与健康研究的复杂性。这些发现与希望将社区参与纳入其研究和倡议的研究人员有关。
{"title":"Public engagement by early career researchers in East Africa during the COVID-19 pandemic: case studies from East Africa","authors":"Trizah K. Milugo, Mary V. Mosha, E. Wampande, Rune N Philemon, Immaculate N. Lwanga, J. Seeley, Nelson K Sewankambo","doi":"10.12688/openresafrica.13897.1","DOIUrl":"https://doi.org/10.12688/openresafrica.13897.1","url":null,"abstract":"Background: Community engagement and involvement (CEI) in research usually depends on face-to-face interactions. However, the COVID-19 pandemic prevented such interactions because of national lockdowns and social distancing. This paper highlights the ways in which early career researchers from East Africa tackled CEI activities during the pandemic. Methods: We provide four case examples that illustrate how early-career researchers based in Kenya, Uganda and Tanzania, deployed different approaches and initiatives to community-engaged research during the pandemic to encourage participation and uptake of research findings. Results: All the three early-career researchers attempted to use virtual/digital means to implement the CEI. However, in each country, this attempt was unsuccessful because of poor connectivity, as well as many poorer students lacking access to telephones and computers. Nevertheless, the researchers effectively engaged the students using different activities (making up songs, drawing comics, and taking part in quizzes) once the schools reopened. Conclusion: These results highlight the complexity of implementing community engagement and involvement in health research when face-to-face interaction is not possible. The findings are relevant to researchers who wish to incorporate community engagement in their research and initiatives.","PeriodicalId":74358,"journal":{"name":"Open research Africa","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45028156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lumefantrine pressure selects nonsynonymous mutation in cysteine desulfurase IscS gene in the rodent malaria parasite Plasmodium berghei ANKA 甲苯胺压力在啮齿动物疟原虫伯氏疟原虫中选择半胱氨酸脱硫酶IscS基因的非同义突变
Pub Date : 2023-03-07 DOI: 10.12688/openresafrica.13457.2
Beatrice Gachie, Jean Chepngetich, Brenda Muriithi, Kelvin Thiong’o, Jeremiah Gathirwa, Francis Kimani, Peter Mwitari, Gabriel Magoma, Daniel Kiboi
Background: Lumefantrine (LM), piperaquine (PQ), and amodiaquine (AQ) are the essential long-acting partner drugs in the artemisinin-based combination therapies (ACTs) treatment regimens globally. The recent report on the emergence of artemisinin-resistant parasites portends an imminent failure of the partner drug in clearing the high residual parasite densities. Understanding the resistance mechanisms to partner drugs remains critical for tracking resistant parasites. Cysteine desulfurase IscS (nfs1), one of the proteins involved in the iron-sulfur (FeS) biogenesis pathway, has been implicated in mediating malaria parasite drug resistance. Methods: Using the rodent malaria parasites Plasmodium berghei ANKA in mice, we assessed whether the nfs1 gene is associated with LM, PQ, and AQ resistance. We first verified the stability of the LM, PQ, and AQ-resistant parasites in the standard 4-Day Suppressive Test. By means of PCR and sequencing analysis, we probed for single nucleotide polymorphisms (SNPs) in the nfs1 gene. Using qPCR, we then measured the expression of the nfs1 gene in resistant parasites relative to the drug-sensitive parent parasites. Results: Our analyses of nfs1 reveal a non-synonymous Gln142Arg mutation in the LM and PQ-resistant parasites. This mutation was not detected in the AQ-resistant parasites. The mRNA quantification of the nfs1 gene reveals differential expression in both LM and PQ-resistant parasites. Conversely, nfs1 expression remained unchanged in the AQ-resistant parasites. Conclusion: Our data suggest that LM and PQ selection pressure induces nonsynonymous mutation and differential expression of the nfs1 gene in Plasmodium berghei. Collectively, these findings provide a premise for investigating LM and PQ resistance mechanisms in both P. berghei and P. falciparum.
背景:氨芳汀(LM)、哌喹(PQ)和阿莫地喹(AQ)是全球以青蒿素为基础的联合疗法(ACTs)治疗方案中必不可少的长效伴用药。最近关于出现青蒿素耐药寄生虫的报告预示着伴侣药物在清除高残留寄生虫密度方面即将失败。了解对伴侣药物的耐药机制对于追踪耐药寄生虫仍然至关重要。半胱氨酸脱硫酶IscS (nfs1)是参与铁硫(FeS)生物发生途径的蛋白之一,在介导疟疾寄生虫耐药性过程中发挥了重要作用。方法:采用小鼠感染的伯氏疟原虫ANKA检测nfs1基因是否与LM、PQ和AQ耐药相关。我们首先在标准的4天抑制试验中验证了LM、PQ和aq耐药寄生虫的稳定性。通过PCR和测序分析,我们检测了nfs1基因的单核苷酸多态性(SNPs)。然后,我们使用qPCR检测了耐药寄生虫中nfs1基因相对于药物敏感亲本寄生虫的表达。结果:我们对nfs1的分析显示,在LM和pq抗性寄生虫中存在非同义的Gln142Arg突变。该突变未在抗aq寄生虫中检测到。nfs1基因的mRNA定量分析显示,在LM和pq抗性寄生虫中,nfs1基因的表达存在差异。相反,nfs1的表达在抗aq寄生虫中保持不变。结论:我们的数据表明,LM和PQ选择压力诱导了伯格氏疟原虫nfs1基因的非同义突变和差异表达。总之,这些发现为研究柏氏疟原虫和恶性疟原虫的LM和PQ耐药机制提供了前提。
{"title":"Lumefantrine pressure selects nonsynonymous mutation in cysteine desulfurase IscS gene in the rodent malaria parasite Plasmodium berghei ANKA","authors":"Beatrice Gachie, Jean Chepngetich, Brenda Muriithi, Kelvin Thiong’o, Jeremiah Gathirwa, Francis Kimani, Peter Mwitari, Gabriel Magoma, Daniel Kiboi","doi":"10.12688/openresafrica.13457.2","DOIUrl":"https://doi.org/10.12688/openresafrica.13457.2","url":null,"abstract":"<ns4:p><ns4:bold>Background:</ns4:bold> Lumefantrine (LM), piperaquine (PQ), and amodiaquine (AQ) are the essential long-acting partner drugs in the artemisinin-based combination therapies (ACTs) treatment regimens globally. The recent report on the emergence of artemisinin-resistant parasites portends an imminent failure of the partner drug in clearing the high residual parasite densities. Understanding the resistance mechanisms to partner drugs remains critical for tracking resistant parasites. Cysteine desulfurase IscS (<ns4:italic>nfs1</ns4:italic>), one of the proteins involved in the iron-sulfur (FeS) biogenesis pathway, has been implicated in mediating malaria parasite drug resistance. </ns4:p><ns4:p> <ns4:bold>Methods:</ns4:bold> Using the rodent malaria parasites <ns4:italic>Plasmodium berghei </ns4:italic>ANKA in mice, we assessed whether the <ns4:italic>nfs1</ns4:italic> gene is associated with LM, PQ, and AQ resistance. We first verified the stability of the LM, PQ, and AQ-resistant parasites in the standard 4-Day Suppressive Test. By means of PCR and sequencing analysis, we probed for single nucleotide polymorphisms (SNPs) in the <ns4:italic>nfs1</ns4:italic> gene. Using qPCR, we then measured the expression of the nfs1 gene in resistant parasites relative to the drug-sensitive parent parasites. </ns4:p><ns4:p> <ns4:bold>Results:</ns4:bold> Our analyses of nfs1 reveal a non-synonymous Gln142Arg mutation in the LM and PQ-resistant parasites. This mutation was not detected in the AQ-resistant parasites. The mRNA quantification of the <ns4:italic>nfs1</ns4:italic> gene reveals differential expression in both LM and PQ-resistant parasites. Conversely, nfs1 expression remained unchanged in the AQ-resistant parasites.</ns4:p><ns4:p> <ns4:bold>Conclusion:</ns4:bold> Our data suggest that LM and PQ selection pressure induces nonsynonymous mutation and differential expression of the nfs1 gene in <ns4:italic>Plasmodium berghei</ns4:italic>. Collectively, these findings provide a premise for investigating LM and PQ resistance mechanisms in both <ns4:italic>P. berghei</ns4:italic> and <ns4:italic>P. falciparum</ns4:italic>.</ns4:p>","PeriodicalId":74358,"journal":{"name":"Open research Africa","volume":"144 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136340126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Amodiaquine drug pressure selects nonsynonymous mutations in pantothenate kinase 1, diacylglycerol kinase, and phosphatidylinositol-4 kinase in Plasmodium berghei ANKA 阿莫地喹药物压力选择柏氏疟原虫泛酸激酶1、二酰基甘油激酶和磷脂酰肌醇-4激酶的非同义突变
Pub Date : 2023-03-07 DOI: 10.12688/openresafrica.13436.2
Jean Chepngetich, Brenda Muriithi, Beatrice Gachie, Kevin Thiong'o, Mercy Jepkorir, Jeremiah Gathirwa, Francis Kimani, Peter Mwitari, Daniel Kiboi
Background: Lumefantrine (LM), piperaquine (PQ), and amodiaquine (AQ), the long-acting components of the artemisinin-based combination therapies (ACTs), are a cornerstone of malaria treatment in Africa. Studies have shown that PQ, AQ, and LM resistance may arise independently of predicted modes of action. Protein kinases have emerged as mediators of drug action and efficacy in malaria parasites; however, the link between top druggable Plasmodium kinases with LM, PQ, and AQ resistance remains unclear. Using LM, PQ, or AQ-resistant Plasmodium berghei parasites, we have evaluated the association of choline kinase (CK), pantothenate kinase 1 (PANK1), diacylglycerol kinase (DAGK), and phosphatidylinositol-4 kinase (PI4Kβ), and calcium-dependent protein kinase 1 (CDPK1) with LM, PQ, and AQ resistance in Plasmodium berghei ANKA. Methods: We used in silico bioinformatics tools to identify ligand-binding motifs, active sites, and sequence conservation across the different parasites. We then used PCR and sequencing analysis to probe for single nucleotide polymorphisms (SNPs) within the predicted functional motifs in the CK, PANK1, DAGK, PI4Kβ, and CDPK1. Using qPCR analysis, we finally measured the mRNA amount of PANK1, DAGK, and PI4Kβ at trophozoites and schizonts stages. Results: We reveal sequence conservation and unique ligand-binding motifs in the CK, PANK1, DAGK, PI4Kβ, and CDPK1 across malaria species. DAGK, PANK1, and PI4Kβ possessed nonsynonymous mutations; surprisingly, the mutations only occurred in the AQr parasites. PANK1 acquired Asn394His, while DAGK contained K270R and K292R mutations. PI4Kβ had Asp366Asn, Ser1367Arg, Tyr1394Asn and Asp1423Asn. We show downregulation of PANK1, DAGK, and PI4Kβ in the trophozoites but upregulation at the schizonts stages in the AQr parasites. Conclusions: The selective acquisition of the mutations and the differential gene expression in AQ-resistant parasites may signify proteins under AQ pressure. The role of the mutations in the resistant parasites and the impact on drug responses require further investigations in malaria parasites.
背景:以青蒿素为基础的联合疗法(ACTs)的长效成分Lumefantrine (LM)、哌喹(PQ)和amodiaquine (AQ)是非洲疟疾治疗的基石。研究表明,PQ、AQ和LM耐药可能独立于预测的作用模式而产生。蛋白激酶已成为疟疾寄生虫药物作用和疗效的介质;然而,顶级可用药疟原虫激酶与LM、PQ和AQ耐药之间的关系尚不清楚。利用LM、PQ或AQ抗性的柏氏疟原虫,我们评估了柏氏疟原虫ANKA中胆碱激酶(CK)、泛酸激酶1 (PANK1)、二酰基甘油激酶(DAGK)、磷脂酰肌醇-4激酶(PI4Kβ)和钙依赖性蛋白激酶1 (CDPK1)与LM、PQ和AQ抗性的关系。方法:我们使用硅生物信息学工具鉴定不同寄生虫的配体结合基序、活性位点和序列保守性。然后,我们使用PCR和测序分析来探测CK、PANK1、DAGK、PI4Kβ和CDPK1中预测功能基序内的单核苷酸多态性(snp)。通过qPCR分析,我们最终测定了滋养体和分裂体阶段PANK1、DAGK和PI4Kβ的mRNA量。结果:我们揭示了疟疾物种中CK、PANK1、DAGK、PI4Kβ和CDPK1的序列保守性和独特的配体结合基序。DAGK、PANK1和PI4Kβ具有非同义突变;令人惊讶的是,突变只发生在AQr寄生虫中。PANK1获得Asn394His,而DAGK包含K270R和K292R突变。PI4Kβ有Asp366Asn、Ser1367Arg、Tyr1394Asn和Asp1423Asn。我们发现,在AQr寄生虫的滋养体中,PANK1、DAGK和PI4Kβ下调,但在分裂体阶段上调。结论:抗AQ寄生虫突变的选择性获得和基因的差异表达可能与AQ压力下的蛋白有关。这些突变在耐药寄生虫中的作用以及对药物反应的影响需要在疟疾寄生虫中进一步研究。
{"title":"Amodiaquine drug pressure selects nonsynonymous mutations in pantothenate kinase 1, diacylglycerol kinase, and phosphatidylinositol-4 kinase in Plasmodium berghei ANKA","authors":"Jean Chepngetich, Brenda Muriithi, Beatrice Gachie, Kevin Thiong'o, Mercy Jepkorir, Jeremiah Gathirwa, Francis Kimani, Peter Mwitari, Daniel Kiboi","doi":"10.12688/openresafrica.13436.2","DOIUrl":"https://doi.org/10.12688/openresafrica.13436.2","url":null,"abstract":"<ns4:p><ns4:bold>Background:</ns4:bold> Lumefantrine (LM), piperaquine (PQ), and amodiaquine (AQ), the long-acting components of the artemisinin-based combination therapies (ACTs), are a cornerstone of malaria treatment in Africa. Studies have shown that PQ, AQ, and LM resistance may arise independently of predicted modes of action. Protein kinases have emerged as mediators of drug action and efficacy in malaria parasites; however, the link between top druggable <ns4:italic>Plasmodium</ns4:italic> kinases with LM, PQ, and AQ resistance remains unclear. Using LM, PQ, or AQ-resistant <ns4:italic>Plasmodium berghei</ns4:italic> parasites, we have evaluated the association of choline kinase (CK), pantothenate kinase 1 (PANK1), diacylglycerol kinase (DAGK), and phosphatidylinositol-4 kinase (PI4Kβ), and calcium-dependent protein kinase 1 (CDPK1) with LM, PQ, and AQ resistance in <ns4:italic>Plasmodium berghei</ns4:italic> ANKA.</ns4:p><ns4:p> <ns4:bold>Methods:</ns4:bold> We used <ns4:italic>in</ns4:italic> <ns4:italic>silico</ns4:italic> bioinformatics tools to identify ligand-binding motifs, active sites, and sequence conservation across the different parasites. We then used PCR and sequencing analysis to probe for single nucleotide polymorphisms (SNPs) within the predicted functional motifs in the CK, PANK1, DAGK, PI4Kβ, and CDPK1. Using qPCR analysis, we finally measured the mRNA amount of PANK1, DAGK, and PI4Kβ at trophozoites and schizonts stages.</ns4:p><ns4:p> <ns4:bold>Results:</ns4:bold> We reveal sequence conservation and unique ligand-binding motifs in the CK, PANK1, DAGK, PI4Kβ, and CDPK1 across malaria species. DAGK, PANK1, and PI4Kβ possessed nonsynonymous mutations; surprisingly, the mutations only occurred in the AQr parasites. PANK1 acquired Asn394His, while DAGK contained K270R and K292R mutations. PI4Kβ had Asp366Asn, Ser1367Arg, Tyr1394Asn and Asp1423Asn. We show downregulation of PANK1, DAGK, and PI4Kβ in the trophozoites but upregulation at the schizonts stages in the AQr parasites.</ns4:p><ns4:p> <ns4:bold>Conclusions:</ns4:bold> The selective acquisition of the mutations and the differential gene expression in AQ-resistant parasites may signify proteins under AQ pressure. The role of the mutations in the resistant parasites and the impact on drug responses require further investigations in malaria parasites.</ns4:p>","PeriodicalId":74358,"journal":{"name":"Open research Africa","volume":"140 3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136335316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The interconnected global emergencies of climate change, food security and health: a call to action by the Science for Africa Foundation. 气候变化、粮食安全和健康等相互关联的全球紧急情况:非洲科学基金会的行动呼吁。
Pub Date : 2023-01-03 eCollection Date: 2023-01-01 DOI: 10.12688/openresafrica.13566.1
Thomas Kariuki, Judith Omumbo, Kabura Ciugu, Elizabeth Marincola

The evidence is clear that climate change is the greatest challenge facing mankind today. Africa is disproportionately burdened by multiple direct and cascading impacts of the climate crisis. Global investments for climate change adaptation, however, have not prioritized Africa adequately and there is a significant knowledge gap in understanding the context and science of climate change and sustainable solutions for the continent's adaptation. Solutions for adaptation and resilience are made complex by an urgent need for accelerated economic growth, rapid population expansion and urbanization, habitat and biodiversity loss and dwindling financing.  There are also challenges in matching policies, wavering commitments and actions with good science that focuses on sustainable lives, livelihoods and ecosystem preservation. The solutions must come from where the impacts are felt. The Science for Africa Foundation supports African researchers and institutions to lead in the science that addresses African priority development areas and has set climate change as a strategic priority. This call to action, by the SFA Foundation, outlines key areas that its strategy addresses through programs that support African scientific excellence, leadership and the best of Africa's research to understand the science of climate change and its impacts; collate and assess evidence for policy; grow high level technical capacity on the continent; and create innovative priority actions for Africa.

有证据表明,气候变化是当今人类面临的最大挑战。气候危机的多重直接和连带影响给非洲造成了不成比例的负担。然而,全球对适应气候变化的投资并没有充分优先考虑非洲,而且在了解气候变化的背景和科学以及非洲大陆适应气候变化的可持续解决方案方面存在着巨大的知识差距。由于迫切需要加快经济增长、人口迅速膨胀和城市化、栖息地和生物多样性丧失以及资金日益减少,适应和恢复能力的解决方案变得十分复杂。 在将政策、摇摆不定的承诺和行动与注重可持续生活、生计和生态系统保护的良好科学相匹配方面也存在挑战。解决方案必须来自能感受到影响的地方。非洲科学基金会支持非洲研究人员和机构在科学领域发挥领导作用,解决非洲优先发展领域的问题,并将气候变化作为战略重点。非洲科学基金会发出的这一行动呼吁概述了其战略所涉及的关键领域,这些计划支持非洲的卓越科学、领导力和非洲的最佳研究,以了解气候变化科学及其影响;整理和评估政策证据;提高非洲大陆的高水平技术能力;以及为非洲制定创新的优先行动。
{"title":"The interconnected global emergencies of climate change, food security and health: a call to action by the Science for Africa Foundation.","authors":"Thomas Kariuki, Judith Omumbo, Kabura Ciugu, Elizabeth Marincola","doi":"10.12688/openresafrica.13566.1","DOIUrl":"10.12688/openresafrica.13566.1","url":null,"abstract":"<p><p>The evidence is clear that climate change is the greatest challenge facing mankind today. Africa is disproportionately burdened by multiple direct and cascading impacts of the climate crisis. Global investments for climate change adaptation, however, have not prioritized Africa adequately and there is a significant knowledge gap in understanding the context and science of climate change and sustainable solutions for the continent's adaptation. Solutions for adaptation and resilience are made complex by an urgent need for accelerated economic growth, rapid population expansion and urbanization, habitat and biodiversity loss and dwindling financing.  There are also challenges in matching policies, wavering commitments and actions with good science that focuses on sustainable lives, livelihoods and ecosystem preservation. The solutions must come from where the impacts are felt. The Science for Africa Foundation supports African researchers and institutions to lead in the science that addresses African priority development areas and has set climate change as a strategic priority. This call to action, by the SFA Foundation, outlines key areas that its strategy addresses through programs that support African scientific excellence, leadership and the best of Africa's research to understand the science of climate change and its impacts; collate and assess evidence for policy; grow high level technical capacity on the continent; and create innovative priority actions for Africa.</p>","PeriodicalId":74358,"journal":{"name":"Open research Africa","volume":"6 ","pages":"1"},"PeriodicalIF":0.0,"publicationDate":"2023-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958300/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10794259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Towards miniaturized electrochemical sensors for monitoring of polychlorinated biphenyls. 多氯联苯监测的小型化电化学传感器研究。
Pub Date : 2023-01-01 DOI: 10.12688/openresafrica.13983.1
Elizabeth Nthambi Ndunda, Moses Mutiso Mwanza

Pollution of our environment as a result of industrialization and other human activities is a growing concern due to the harmful effects of most chemicals that are released into the environment. Of particular interest are the persistent organic pollutants (POPs) that are reported to be toxic and build up in the environment due to their persistence. Among the POPs are polychlorinated biphenyls (PCBs), which were widely used in the past in various applications ranging from additives in pesticides to dielectric fluids in electrical equipment. As a way of protecting the one health trilogy (environment, human and animal health), their determination in the environment is a paramount call that has seen researchers continue to provide advanced technologies towards achieving this goal. These technologies involve the conventional gold standard gas chromatography systems coupled to sensitive detectors that can detect trace level concentrations. They have come in handy in monitoring of PCBs but their application for routing monitoring may not be sustainable because of the cost of operation associated with them and the need for experts to run the equipment. As a result, there is need for affordable systems that are still able to achieve the required sensitivity for routine monitoring and real-time data acquisition. Sensor systems fit very well in this category since they can be miniaturized for affordability and portray many other desirable features. PCBs as environmentally relevant environmental pollutants have received minimal attention with regards to sensor development and this review highlights the efforts that have been made so far. It provides in-depth discussions on electrochemical sensors and the various modifications that have been employed to date to achieve detection of PCBs at low concentrations as well as the future prospects in remote and routine monitoring.

由于工业化和其他人类活动造成的环境污染日益引起人们的关注,这是由于大多数化学物质被释放到环境中的有害影响。特别令人感兴趣的是持久性有机污染物,据报道,持久性有机污染物是有毒的,并因其持久性而在环境中积累。在持久性有机污染物中,多氯联苯(PCBs)在过去被广泛用于各种应用,从农药添加剂到电气设备的介电流体。作为保护同一健康三部曲(环境、人类和动物健康)的一种方式,他们在环境方面的决心是一种最重要的呼吁,研究人员继续为实现这一目标提供先进技术。这些技术包括传统的金标准气相色谱系统与可以检测痕量浓度的敏感检测器相结合。它们在监测多氯联苯方面派上了用场,但由于与它们相关的操作成本和需要专家运行设备,它们在路由监测方面的应用可能无法持续。因此,需要经济实惠的系统,仍然能够实现日常监测和实时数据采集所需的灵敏度。传感器系统非常适合这一类别,因为它们可以小型化,价格合理,并描绘了许多其他理想的功能。多氯联苯作为与环境相关的环境污染物,在传感器开发方面受到的关注很少,本文综述了迄今为止所做的努力。它深入讨论了电化学传感器和迄今为止用于实现低浓度多氯联苯检测的各种修改,以及远程和常规监测的未来前景。
{"title":"Towards miniaturized electrochemical sensors for monitoring of polychlorinated biphenyls.","authors":"Elizabeth Nthambi Ndunda,&nbsp;Moses Mutiso Mwanza","doi":"10.12688/openresafrica.13983.1","DOIUrl":"https://doi.org/10.12688/openresafrica.13983.1","url":null,"abstract":"<p><p>Pollution of our environment as a result of industrialization and other human activities is a growing concern due to the harmful effects of most chemicals that are released into the environment. Of particular interest are the persistent organic pollutants (POPs) that are reported to be toxic and build up in the environment due to their persistence. Among the POPs are polychlorinated biphenyls (PCBs), which were widely used in the past in various applications ranging from additives in pesticides to dielectric fluids in electrical equipment. As a way of protecting the one health trilogy (environment, human and animal health), their determination in the environment is a paramount call that has seen researchers continue to provide advanced technologies towards achieving this goal. These technologies involve the conventional gold standard gas chromatography systems coupled to sensitive detectors that can detect trace level concentrations. They have come in handy in monitoring of PCBs but their application for routing monitoring may not be sustainable because of the cost of operation associated with them and the need for experts to run the equipment. As a result, there is need for affordable systems that are still able to achieve the required sensitivity for routine monitoring and real-time data acquisition. Sensor systems fit very well in this category since they can be miniaturized for affordability and portray many other desirable features. PCBs as environmentally relevant environmental pollutants have received minimal attention with regards to sensor development and this review highlights the efforts that have been made so far. It provides in-depth discussions on electrochemical sensors and the various modifications that have been employed to date to achieve detection of PCBs at low concentrations as well as the future prospects in remote and routine monitoring.</p>","PeriodicalId":74358,"journal":{"name":"Open research Africa","volume":"6 ","pages":"5"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192943/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10350374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biobanking in East and Central Africa: A case of the Integrated Biorepository of H3Africa Uganda. 东非和中非的生物库:乌干达 H3Africa 综合生物库案例。
Pub Date : 2022-09-30 eCollection Date: 2022-01-01 DOI: 10.12688/openresafrica.13495.1
Gideon Nsubuga, David Patrick Kateete, Sharley Melissa Aloyo, Lwanga Newton Kigingi, Nasinghe Emmanuel, Kezimbira Dafala, Moses Levi Ntayi, Moses L Joloba, Kamulegeya Rogers

Biorepositories are essential because they guarantee the proper storage and distribution of biospecimens and their associated data for current and future research. In Eastern and Central Africa, the Integrated Biorepository of H3Africa Uganda (IBRH3AU) at Makerere University in Uganda was the first of its kind. It is strategically located at Makerere University College of Health Sciences, which is home to some of Uganda's most relevant and impactful infectious and non-infectious disease research.  Since its inception as a pilot project in 2012, the IBRH3AU biorepository has grown into a state-of-the-art facility serving the H3Africa consortium and the rest of the scientific community. IBRH3AU has built a solid infrastructure over the past ten years with cutting-edge methods and technologies for the collection, processing, quality control, handling, management, storage and shipment of biospecimens. H3Africa researchers, local researchers, postgraduate and postdoctoral students, and the greater scientific community in Eastern and Central Africa and beyond have benefited from IBRH3AU's exceptional biobanking services.

生物样本库是至关重要的,因为它们保证了生物样本及其相关数据的妥善储存和分发,以用于当前和未来的研究。在非洲东部和中部,乌干达马凯雷雷大学的乌干达 H3Africa 综合生物样本库(IBRH3AU)是首个此类机构。它位于马凯雷雷大学健康科学学院,这里是乌干达一些最具相关性和影响力的传染病和非传染病研究的所在地,地理位置十分优越。 自 2012 年作为试点项目启动以来,IBRH3AU 生物储存库已发展成为最先进的设施,为 H3Africa 联盟和科学界其他成员提供服务。在过去十年中,IBRH3AU 利用生物样本收集、处理、质量控制、处理、管理、存储和运输方面的先进方法和技术,建立了坚实的基础设施。H3Africa 的研究人员、当地研究人员、研究生和博士后以及东部和中部非洲及其他地区的广大科学界都受益于 IBRH3AU 卓越的生物样本库服务。
{"title":"Biobanking in East and Central Africa: A case of the Integrated Biorepository of H3Africa Uganda.","authors":"Gideon Nsubuga, David Patrick Kateete, Sharley Melissa Aloyo, Lwanga Newton Kigingi, Nasinghe Emmanuel, Kezimbira Dafala, Moses Levi Ntayi, Moses L Joloba, Kamulegeya Rogers","doi":"10.12688/openresafrica.13495.1","DOIUrl":"10.12688/openresafrica.13495.1","url":null,"abstract":"<p><p>Biorepositories are essential because they guarantee the proper storage and distribution of biospecimens and their associated data for current and future research. In Eastern and Central Africa, the Integrated Biorepository of H3Africa Uganda (IBRH3AU) at Makerere University in Uganda was the first of its kind. It is strategically located at Makerere University College of Health Sciences, which is home to some of Uganda's most relevant and impactful infectious and non-infectious disease research.  Since its inception as a pilot project in 2012, the IBRH3AU biorepository has grown into a state-of-the-art facility serving the H3Africa consortium and the rest of the scientific community. IBRH3AU has built a solid infrastructure over the past ten years with cutting-edge methods and technologies for the collection, processing, quality control, handling, management, storage and shipment of biospecimens. H3Africa researchers, local researchers, postgraduate and postdoctoral students, and the greater scientific community in Eastern and Central Africa and beyond have benefited from IBRH3AU's exceptional biobanking services.</p>","PeriodicalId":74358,"journal":{"name":"Open research Africa","volume":"5 ","pages":"33"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175960/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9876112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lumefantrine pressure selects nonsynonymous mutation in cysteine desulfurase IscS gene in the rodent malaria parasite Plasmodium berghei ANKA 甲苯胺压力在啮齿动物疟原虫伯氏疟原虫中选择半胱氨酸脱硫酶IscS基因的非同义突变
Pub Date : 2022-08-09 DOI: 10.12688/openresafrica.13457.1
B. Gachie, Jean Chepngetich, Brenda Muriithi, Kelvin Thiong’o, J. Gathirwa, F. Kimani, P. Mwitari, G. Magoma, Daniel Kiboi
Background: Lumefantrine (LM), piperaquine (PQ), and amodiaquine (AQ) are the essential long-acting partner drugs in the artemisinin-based combination therapies (ACTs) treatment regimens globally. Understanding the resistance mechanisms to partner drugs remains critical for tracking resistant parasites. Cysteine desulfurase IscS (nfs1), one of the proteins involved in the iron-sulfur (FeS) biogenesis pathway, has been implicated in mediating malaria parasite drug resistance.   Methods: Using the rodent malaria parasites Plasmodium berghei ANKA in mice, we assessed whether the nfs1 gene is associated with LM, PQ, and AQ resistance. By means of PCR and sequencing analysis, we probed for single nucleotide polymorphisms (SNPs) within the nfs1 gene. Using qPCR, we then measured the expression of the nfs1 gene in resistant parasites relative to the drug-sensitive parent parasites.  Results: Our analyses of nfs1 reveal a non-synonymous Gln142Arg mutation in the LM and PQ-resistant parasites. This mutation was not detected in the AQ-resistant parasites. The mRNA quantification of the nfs1 gene reveals significant downregulation in both LM and PQ-resistant parasites compared to the drug-sensitive wild-type (WT) parasites. Conversely, nfs1 expression was upregulated in the AQ-resistant schizont stage compared to the WT parasites.   Conclusion: Our data suggest that LM and PQ selection pressure induces nonsynonymous mutation and nfs1 downregulation of its expression in Plasmodium berghei. Collectively, these findings provide a premise for investigating LM and PQ resistance mechanisms in both P. berghei and P. falciparum.
背景:氨芳汀(LM)、哌喹(PQ)和阿莫地喹(AQ)是全球以青蒿素为基础的联合疗法(ACTs)治疗方案中必不可少的长效伴用药。了解对伴侣药物的耐药机制对于追踪耐药寄生虫仍然至关重要。半胱氨酸脱硫酶IscS (nfs1)是参与铁硫(FeS)生物发生途径的蛋白之一,在介导疟疾寄生虫耐药性过程中发挥了重要作用。方法:采用小鼠感染的伯氏疟原虫ANKA检测nfs1基因是否与LM、PQ和AQ耐药相关。通过PCR和测序分析,探讨了nfs1基因的单核苷酸多态性(snp)。然后,我们使用qPCR检测了耐药寄生虫中nfs1基因相对于药物敏感亲本寄生虫的表达。结果:我们对nfs1的分析显示,在LM和pq抗性寄生虫中存在非同义的Gln142Arg突变。该突变未在抗aq寄生虫中检测到。nfs1基因的mRNA定量显示,与药敏野生型(WT)寄生虫相比,LM和pq耐药寄生虫中nfs1基因的表达均显著下调。相反,与WT寄生物相比,nfs1在抗aq分裂体阶段表达上调。结论:我们的数据表明,LM和PQ选择压力诱导了伯格氏疟原虫非同义突变和nfs1表达下调。总之,这些发现为研究柏氏疟原虫和恶性疟原虫的LM和PQ耐药机制提供了前提。
{"title":"Lumefantrine pressure selects nonsynonymous mutation in cysteine desulfurase IscS gene in the rodent malaria parasite Plasmodium berghei ANKA","authors":"B. Gachie, Jean Chepngetich, Brenda Muriithi, Kelvin Thiong’o, J. Gathirwa, F. Kimani, P. Mwitari, G. Magoma, Daniel Kiboi","doi":"10.12688/openresafrica.13457.1","DOIUrl":"https://doi.org/10.12688/openresafrica.13457.1","url":null,"abstract":"Background: Lumefantrine (LM), piperaquine (PQ), and amodiaquine (AQ) are the essential long-acting partner drugs in the artemisinin-based combination therapies (ACTs) treatment regimens globally. Understanding the resistance mechanisms to partner drugs remains critical for tracking resistant parasites. Cysteine desulfurase IscS (nfs1), one of the proteins involved in the iron-sulfur (FeS) biogenesis pathway, has been implicated in mediating malaria parasite drug resistance.   Methods: Using the rodent malaria parasites Plasmodium berghei ANKA in mice, we assessed whether the nfs1 gene is associated with LM, PQ, and AQ resistance. By means of PCR and sequencing analysis, we probed for single nucleotide polymorphisms (SNPs) within the nfs1 gene. Using qPCR, we then measured the expression of the nfs1 gene in resistant parasites relative to the drug-sensitive parent parasites.  Results: Our analyses of nfs1 reveal a non-synonymous Gln142Arg mutation in the LM and PQ-resistant parasites. This mutation was not detected in the AQ-resistant parasites. The mRNA quantification of the nfs1 gene reveals significant downregulation in both LM and PQ-resistant parasites compared to the drug-sensitive wild-type (WT) parasites. Conversely, nfs1 expression was upregulated in the AQ-resistant schizont stage compared to the WT parasites.   Conclusion: Our data suggest that LM and PQ selection pressure induces nonsynonymous mutation and nfs1 downregulation of its expression in Plasmodium berghei. Collectively, these findings provide a premise for investigating LM and PQ resistance mechanisms in both P. berghei and P. falciparum.","PeriodicalId":74358,"journal":{"name":"Open research Africa","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47101070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Open research Africa
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1